Literature DB >> 18463670

Sympathetic nerve hyperactivity of essential hypertension is lower in postmenopausal women than men.

A J Hogarth1, J Burns, A F Mackintosh, D A S G Mary.   

Abstract

Sympathetic activation has been associated with the development and complications of hypertension. While the prevalence of hypertension and its cardiovascular risks in women are found to be less than in men and tend to become similar to men after the menopause, there have been no data on the level of sympathetic activation in postmenopausal women relative to men. Therefore, we planned to find out whether muscle sympathetic nerve hyperactivity of essential hypertension (EHT) in postmenopausal women is different from that in matched men. We quantified muscle sympathetic nerve activity (MSNA) as mean frequency of single units (s-MSNA) and multiunit bursts (b-MSNA) in 21 postmenopausal women with EHT (W-EHT) relative to 21 matched men with EHT (M-EHT), in comparison to two control groups of 21 normal women (W-NC) and 21 men (M-NC), respectively. The EHT groups had greater MSNA indices than NC groups. W-EHT had lower (P<0.05) s-MSNA (63+/-22.7 impulses per 100 cardiac beats) than M-EHT (78+/-11.2 impulses per 100 cardiac beats). W-NC had lower (P<0.05) s-MSNA (53+/-12.4 impulses per 100 cardiac beats) than M-NC (65+/-16.3 impulses per 100 cardiac beats). Similar results were obtained for b-MSNA. Postmenopausal women with EHT had lower level of central sympathetic hyperactivity than men. Similarly, normal postmenopausal women had lower MSNA than men. These findings suggest that postmenopausal women continue to have a lower sympathetic nerve activity than men even after the development of EHT, and that this could have implications for gender-specific management of hypertension.

Entities:  

Mesh:

Year:  2008        PMID: 18463670     DOI: 10.1038/jhh.2008.31

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  9 in total

Review 1.  The role of cardiac autonomic function in hypertension and cardiovascular disease.

Authors:  Paolo Palatini; Stevo Julius
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 2.  Central mineralocorticoid receptors, sympathetic activity, and hypertension.

Authors:  Frances McManus; Scott M MacKenzie; E Marie Freel
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

Review 3.  Hypertension in postmenopausal women.

Authors:  Roberta Lima; Marion Wofford; Jane F Reckelhoff
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

Review 4.  BP regulation VI: elevated sympathetic outflow with human aging: hypertensive or homeostatic?

Authors:  J Andrew Taylor; Can Ozan Tan
Journal:  Eur J Appl Physiol       Date:  2013-09-28       Impact factor: 3.078

Review 5.  Postmenopausal hypertension.

Authors:  Licy L Yanes; Jane F Reckelhoff
Journal:  Am J Hypertens       Date:  2011-04-21       Impact factor: 2.689

6.  Electrophysiological and neuroanatomical evidence of sexual dimorphism in aortic baroreceptor and vagal afferents in rat.

Authors:  Bai-Yan Li; Guo-Fen Qiao; Bin Feng; Rui-Bo Zhao; Yan-Jie Lu; John H Schild
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-08-06       Impact factor: 3.619

7.  Microneurographic research in women.

Authors:  Qi Fu
Journal:  Front Physiol       Date:  2012-07-18       Impact factor: 4.566

8.  Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes.

Authors:  Carolina López-Cano; Liliana Gutiérrez-Carrasquilla; Enric Sánchez; Jessica González; Andree Yeramian; Raquel Martí; Marta Hernández; Gonzalo Cao; Mercè Ribelles; Xavier Gómez; Silvia Barril; Ferran Barbé; Cristina Hernández; Rafael Simó; Albert Lecube
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-01       Impact factor: 5.555

9.  Characterization of persistent TTX-R Na+ currents in physiological concentration of sodium in rat visceral afferents.

Authors:  Guo-Fen Qiao; Bai-Yan Li; Yu-Hong Zhou; Yan-Jie Lu; John H Schild
Journal:  Int J Biol Sci       Date:  2009-04-03       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.